Interactions of Aβ with endogenous anti-inflammatory agents: A basis for chronic neuroinflammation in Alzheimer's disease

Neurobiology of Disease

Volumn 10, Issue 3, 2002, Pages 187-200

  Janciauskiene, S ^a   Sun, Yong Xin ^a   Wright, H T ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN E; CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE; PROTEINASE INHIBITOR; PROTEOGLYCAN; STATIN;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BRAIN; BRAIN INJURY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; HUMAN; INFLAMMATION; MICROGLIA; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0036403855     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0519     Document Type: Review

References (187)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. 1-antichymotrypsin. Neurobiol. Aging 11, 123-129.
3. 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo.Ann. N.Y. Acad. Sci. 920, 245-248.
4. 1-antichymotrypsin in Alzheimer's disease. Neurobiol. Aging 22, 931-936.
5. Aisen, P. S. (1997) Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontology 43, 143-149.
6. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R., McGeer, P. L., O'Banion, M. K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F. L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., & Wyss-Coray, T. (2000) Inflammation and Alzheimer's disease. Neuroinflammation working group. Neurobiol. Aging 21, 383-421.
7. Aksenova, M. V., Aksenov, M. Y., Butterfield, D. A., & Carney, J. M. (1996) alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci. Lett. 211, 45-48.
8. Aleshkov, S., Abraham, C. R. & Zannis, V. I. (1997) Interaction of nascent apoE2, apoE3, and apoE4 isoforms expressed in mammalian cells with amyloid peptide β(1-40): Relevance to Alzheimer's disease. Biochemistry 36, 10571-10580.
9. Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M., & Hofman, A. (1995) Neurology 45, 1441-1445.
10. Apelt, J., & Schliebs, R. (2001) Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 894, 21-30.
11. Bach-Ngohou, K., Nazih, H., Nazih-Sanderson, F., Zair, Y., Le Carrer, D., Krempf, M., & Bard, J. M. (2001) Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo. In. J. Obes. Relat. Metab. Disord. 25, 1752-1758.
12. Bales, K. R., Verina, T., Dodel, R. C., Du, Y. S., Altstiel, L., Bender, M. Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., Piccardo, P., Ghetti, B. & Paul, S. M. (1997) Lack of apolipoprotein E dramatically reduces amylid β-peptide depoosition. Nat. Genet. 17, 263-264.
13. Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., Ghetti, B., & Paul, S. M. (1999) Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96, 15233-15238.
14. Bame, K. J., Danda, J., Hassall, A., & Tumova, S. (1997) Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. J. Biol. Chem. 272, 17005-17011.
15. Baskin, F., Rosenberg, R. N., & Davis, R. M. (1992) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. J. Neurosci. Res. 32, 274-279.
16. Benveniste, E. N., Nguyen, V. T., & O'Keefe, G. M. (2001) Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochemistry Int. 39, 381-391.
17. Bianca, V. D., Dusi, S., Bianchini, E., Dal Pra, I., & Rossi, F. (1999) beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J. Biol. Chem. 274, 15493-15499.
18. Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., & Selkoe, D. J. (1996) Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271, 32916-32922.
19. 2-macroglobulin is genetically associated with Alzheimer disease. Nature Genetics 19, 357-360.
20. Blanchard, B. J., Konopka, G., Russell, M., & Ingram, V. M. (1997) Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease. Brain Res. 776, 40-50.
21. Bodmer, S., Podlisny, M. B., Selkoe, D. J., Heid, I., & Fontana, A. (1990) Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. Biochem. Biophys. Res. Commun. 171, 890-897.
22. Bodovitz, S., & Klein, W. L. (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440.
23. Bohrmann, B., Tjernberg, L., Kuner, P., Poli, S., Levet-Trafit, B., Naslund, J., Richards, G., Huber, W., Dobeli, H., & Nordstedt, C. (1999) Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 274, 15990-15995.
24. Bonay, P., & Avila, J. (2001) Apolipoprotein E4 stimulates sulfation of glycosaminoglycans in neural cells. Biochim. Biophys. Acta 1535, 217-220.
25. Bondeson, J. (1996) Effects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: A review. Gen. Pharmacol. 27, 943-956.
26. Bottner, M., Unsicker, K., & Suter-Crazzolara, C. (1996) Expression of TGF-beta type II receptor mRNA in the CNS. Neuroreport. 7, 2903-2907.
27. Breitner, J. C. (1996a) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Ann. Rev. Med. 47, 401-411.
28. Breitner, J. C. (1996b) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 17, 789-794.
29. Buee, L., Ding, W., Delacourte, A., & Fillit, H. (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601, 154-163.
30. Chang, J. W., Young, D. A., Coleman, P. D., & O'Banion, M. K. (2001) Two-dimensional gel analysis of secreted proteins induced by interleukin-1 beta in rat astrocytes. Neurochem. Int. 39, 349-359.
31. Charge, S. B., Esiri, M. M., Bethune, C. A., Hansen, B. C., & Clark, A. (1996) Apolipoprotein E is associated with islet amyloid and other amyloidoses: Implications for Alzheimer's disease. J. Pathol. 179, 443-447.
32. Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., & Morris, R. G. (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979.
33. Choi-Miura, N. H., Ihara, Y., Fukuchi, K., Takeda, M., Nakano, Y., Tobe, T., & Tomita, M. (1992) SP-40,40 is a constituent of Alzheimer's amyloid. Acta. Neuropath. 83, 260-264.
34. Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B. & Landreth, G. E. (2000) Inflammatory mechanisms in Alzheimer's disease: Inhibition of β = -amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J. Neurosci. 20, 558-567.
35. Cotman, S. L., Halfter, W., & Cole, G. J. (2000) Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell Neurosci. 15, 183-198.
36. Das, S., & Potter, H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456.
37. Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M. G., & Forloni, G. (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188, 70-74.
38. Du, Y., Ni, B., Glinn, M., Dodel, R. C., Bales, K. R., Zhang, Z., Hyslop, P. A., & Paul, S. M. (1997) alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J. Neurochem. 69, 299-305.
39. Du, Y., Bales, K. R., Dodel, R. C., Liu, X., Glinn, M. A., Horn, J. W., Little, S. P., & Paul, S. M. (1998) Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neuro-toxicity of cultured fetal rat cortical neurons. J. Neurochem. 70, 1182-1188.
40. El-Agnaf, O. M., Mahil, D. S., Patel, B. P., & Austen, B. M. (2000) Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease. Biochem. Biophys. Res. Commun. 273, 1003-1007.
41. Eriksson, S., Janciauskiene, S., & Lannfelt, L. (1995) Alpha 1-anti-chymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. USA 92, 2313-2317.
42. Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H. & Lansbury, P. T. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92, 763-767.
43. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., & Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 5856-5861.
44. Ferrer-Lopez, P., Renesto, P., Schattner, M., Bassot, S., Laurent, P., & Chignard, M. (1990) Activation of human platelets by C5a-stimulated neutrophils: A role for cathepsin G. Am. J. Physiol. 258, C1100-1107.
45. Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R., & Pasinetti, G. M. (1993) TGF-beta 1 is an organizer of responses to neurode-generation. J. Cell Biochem. 53, 314-322.
46. Fitch, M. T., & Silver, J. (1997) Activated macrophages and the blood-brain barrier: Inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 148, 587-603.
47. Fraser, P. E., Nguyen, J. T., Chin, D. T. & Kirschner, D. A. (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
48. 1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 61, 298-305.
49. Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. M. (1999) The role of cholesterol in the biosynthesis of beta-amyloid. Neurorepor. 10, 1699-1705.
50. Gallagher, J. T. (1997) Structure-activity relationship of heparan sulphate. Biochem. Soc. Trans. 25, 1206-1209.
51. Gebicke-Haerter, P. J., Spleiss, O., Ren, L. Q., Li, H., Dichmann, S., Norgauer, J., Boddeke, H. W. (2001) Microglial chemokines and chemokine receptors. Prog. Brain Res. 132, 525-532.
52. Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T. & Frangione, B. (1993) The cerebrospinal-fluid form of Alzheimer's amyloid beta is complexed to SP-40,40 (apo-lipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27-30.
53. Giometto, B., Argentiero, V., Sanson, F., Ongaro, G., & Tavolato, B. (1988) Acute-phase proteins in Alzheimer's disease. Eur. Neurol. 28, 30-33.
54. Gitter, B. D., Cox, L. M., Rydel, R. E., & May, P. C. (1995) Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA 92, 10738-10741.
55. Goddard, D. R., Bunning, R. A., & Woodroofe, M. N. (2001) Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia 34, 267-271.
56. Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
57. Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V., Perrot, L. J., White, C. L. 3rd, & Araoz, C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
58. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281.
59. Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'Cytokine Cycle' in disease progression. Brain Pathol. 8, 65-72.
60. Haga, S., Ikeda, K., Sato, M., Ishii, T. (1993) Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601, 88-94.
61. Hamazaki, H. (1995) Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. J. Biol. Chem. 270, 10392-10394.
62. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) Protofibrillar inermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884.
63. Hartmann, T. (2001) Cholesterol, Aβ and Alzheimer's disease. Trends Neurosci. 24, S45-S48.
64. Holcomb, L. A., Gordon, M. N., Benkovic, S. A. & Morgan, D. G. (2000) A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity. Mech. Ageing Dev. 112, 135-152.
65. Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S., Brown, F., Wetzel, R., Wood, S. J., Camilleri, P., & Roberts, G. W. (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
66. Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G. Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228-3233.
67. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274, 99-102.
68. Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785, 195-206.
69. Huang, S. S., Huang, F. W., Xu, J., Chen, S., Hsu, C. Y., & Huang, J. S. (1998) Amyloid beta-peptide possesses a transforming growth factor-beta activity. J. Biol. Chem. 273, 27640-27644.
70. 2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA 95, 3275-3280.
71. Hussaini, I. M., Brown, M. D., Karns, L. R., Carpenter, J., Redpath, G. T., Gonias, S. L., & Vandenberg, S. R. (1999) Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia 25, 71-84.
72. Ignatius, M. J., Gebicke-Harter, P. J., Skene, J. H. P., Schilling, J. W., Weisgraber, K. H., Mahley, R. W. & Shooter, E.M. (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA 83, 1125-1129.
73. Ikeda, U., & Shimada, K. (2001) The antiinflammatory effects of statins. N. Engl. J. Med. 345, 1210.
74. Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K., & Hyman, B. T. (1997a) APPS transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965-73.
75. Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., Hyman, B. T. (1997b) Aβ deposition is associated with neuropil change, but not overt neuronal loss in human amyloid precursor V717F (PD-APP) transgenic mice. J. Neurosci. 17, 7053-7059.
76. Itagki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182.
77. Janciauskiene, S., Eriksson, S., & Wright, H. T. (1996) A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin. Nat. Struct. Biol. 3, 668-671.
78. Janciauskiene, S., Rubin, H., Lukacs, C. M., & Wright, H. T. (1998) Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J. Biol. Chem. 273, 28360-28364.
79. Janciauskiene, S., & Wright, H. T. (1998) Inflammation, antichymotrypsin, and lipid metabolism: Autogenic etiology of Alzheimer's disease. Bioessays 20, 1039-1046.
80. Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S., & Drachman, D. A. (2000) Statins and the risk of dementia. Lancet 356, 1627-1631.
81. Jordan, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S. & LaDu, M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195-204.
82. Kalaria, R. N. (1999) Microglia and Alzheimer's Disease. Curr. Opin. Hematol. 6, 15-24
83. 1-antichymotrypsin on the risk of Alzheimer disease. Genomics 40, 382-384.
84. Kang, D. E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L. A., Thomas, R. G., Thal, L. J., Katzman, R. (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49, 56-61.
85. Kang, J., Park, E. J., Jou, I., Kim, J. H., & Joe, E. H. (2001) Reactive oxygen species mediate A beta(25-35)-induced activation of BV-2 microglia. Neuroreport 12, 1449-1452.
86. Kilpatrick, L., McCawley, L., Nachiappan, V., Greer, W., Majumdar, S., Korchak, H. M., & Douglas, S. D. (1992) Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J. Immunol. 149, 3059-3065.
87. Kisilevsky, R. (1994) Proteoglycans and other bsement membrane proteins in amyloidoses. Mol. Neurobiol. 9, 23-24.
88. Klein, W. L., Krafft, G. A. & Finch, C. E. (2001) Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-223.
89. 1-antichymotrypsin in brain may be related to astrogliosis. Neurobiol. Aging 12, 495-501.
90. Kopec, K. K., & Carroll, R. T. (1998) Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J. Neurochem. 71, 2123-2131.
91. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasumin, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. & Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
92. La Du, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) Isoform-specific binding of apolipopro-tein E to β-amyloid. J. Biol. Chem. 269, 23404-23406.
93. LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & van Eldik, L. J. (2000) Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974-33980.
94. LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2001) Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem. Int. 39, 427-34.
95. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., & Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
96. Lauer, D., Reichenbach, A., Birkenmeier, G. (2001) Alpha 2-macro-globulin-mediated degradation of amyloid beta 1-42: A mechanism to enhance amyloid beta catabolism. Exp. Neurol. 167, 385-392.
97. LeVeugle, B., & Fillit, H. (1994) Proteoglycans and the acute-phase response in Alzheimer's disease brain. Mol. Neurobiol. 9, 25-32.
98. Licastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V., & Grimaldi, L. M. (2000a) Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain? J. Neuroimmunol. 103, 97-102.
99. 1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 48, 388-391.
100. Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., & Cole, G. M. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709-5714.
101. Lippa, C. F., Flanders, K. C., Kim, E. S., & Croul, S. (1998) TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: A comparison with aging and progressive supranuclear Neurobiol. Aging 19, 527-33.
102. Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
103. Lopes, M. B., Bogaev, C. A., Gonias, S. L., & VandenBerg, S. R. (1994) Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. FEBS Lett. 338, 301-305.
104. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) Soluble amyloid β-peptide concentration ia a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862.
105. Lukacs, C., & Christianson, D. W. (1996) Is the binding of beta-amyloid protein to antichymotrypsin in Alzheimer plaques mediated by a beta-strand insertion? Proteins 25, 420-424.
106. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 97-94.
107. Ma, J., Yee, A., Brewer, H. B., & Potter, H. (1996) Promotion of the neurotoxicity of Alzheimer Aβ protein by the pathological chaperones ACT and apoE4: Inhibition by Aβ-related peptides and apoE2. Neurobiol. Aging 17, 773-780.
108. Mackiewicz, A., Ganapathi, M. K., Schultz, D., Brabenec, A., Weinstein, J., Kelley, M.F., & Kushner, I. (1990) Transforming growth factor beta 1 regulates production of acute-phase proteins. Proc. Natl. Acad. Sci. USA 87, 1491-1495.
109. Mahley, R. W., Nathan, B. P., & Pitas, R. E. (1996) Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Ann. N. Y. Acad. Sci. 777, 139-145.
110. Marzolo, M. P., von Bernhardi, R., Bu, G., & Inestrosa, N. C. (2000) Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J. Neurosci. Res. 60, 401-411.
111. Matsubara, E., Frangione, B. & Ghiso, J. (1995) Characterization of apolipoprotein J-Alzheimer's Aβ interaction. J. Biol. Chem. 270, 7563-7567.
112. McBride, P. A., Wilson, M. I., Eikelenboom, P., Tunstall, A., & Bruce, M. E. (1998) Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp. Neurol. 149, 447-454.
113. McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
114. McGeer, P. L., Klegeris, A., Walker, D. G., Yasuhara, O., & McGeer, E. G. (1994) Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174, 269-277.
115. McGeer, P. L. Schulzer, M., & McGeer, E. G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47, 425-432.
116. McGeer, P. L. & Mcgeer, E. G. (1999) Inflammation of the brain in Alzheimer's disease: Implications for therapy. J. Leukoc. Biol. 65, 409-415.
117. McGeer, P. L., & McGeer, E. G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22, 799-809.
118. McLaurin, J., Franklin, T., Kuhns, W. J., & Fraser, P. E. (1999) A sulfated proteoglycan aggregation factor mediates amyloid-beta peptide fibril formation and neurotoxicity. Amyloid 6, 233-243.
119. McLaurin, J., & Fraser, P. E. (2000) Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. Eur. J. Biochem. 267, 6353-6361.
120. Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L. Jr., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
121. Meda, L., Baron, P., Prat, E., Scarpini, E., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid [25-35]. J. Neuroimmunol. 93, 45-52.
122. Miyata, M., & Smith, J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nature Genetics 14, 55-61.
123. 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
124. Mucke, L., Yu, G., McConlogue, L., Rockenstein, E. M., Abraham, C. R., & Masliah, E. (2000b) Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am. J. Pathol. 157, 2003-2010.
125. Munson, G. W., Roher, A. E., Kuo, Y. M., Gilligan, S. M., Reardon, C. A., Getz, G. S., & LaDu, M. J. (2000) SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides. Biochemistry 39, 16119-16124.
126. Naidoo, N., Cooperman, B. S., Wang, Z. M., Liu, X. Z., & Rubin, H. (1995) Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements. J. Biol. Chem. 270, 14548-14555.
127. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease kuru plaque amyloid in Cretuzfeldt-Jacob disease. Brain Res. 541, 163-166.
128. Narindrasorasak, S., Lowery, D., Gonzalez-DeWhitt, P., Poorman, R. A., Greenberg, B. & Kisilevsky, R. (1991) High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883.
129. Narita, M., Bu, G., Holtzman, D. M., & Schwartz, A. L. (1997a) The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 68, 587-95.
130. Narita, M., Holtzman, D. M., Schwartz, A. L., & Bu, G. (1997b) Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69, 1904-1911.
131. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
132. 1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 1441-1451.
133. Nilsson, L. N., Das, S., & Potter, H. (2001b) Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: Significance for Alzheimer's disease. Neurochem. Int. 39, 361-370.
134. Pasternack, J. M., Abraham, C. R., Van Dyke, B. J., Potter, H. & Younkin, S. G. (1989) Astrocytes in Alzheimer's disease gray matter express alpha1-antichymotrypsin mRNA. Am. J. Pathol. 135, 827-834.
135. Perlmutter, L. S. & Chui, H. C. (1990) Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review. Brain Res. Bull. 24, 677-686.
136. Perlmutter, L. S., Chui, H. C., Saperia, D. & Athanikar, J. (1990) Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res. 508, 13-19.
137. Perlmutter, L. S., Barron, E., Saperia, D. & Chui, H. C. (1991) Association between vascular basement membrane components and the lesions of Alzheimer's disease. J. Neurosci. Res. 30, 673-681.
138. Permanne, B., Perez, C., Soto, C., Frangione, B., & Wisniewski, T. (1997) Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants. Biochem. Biophys. Res. Commun. 240, 715-720.
139. Poirier, J., Hess, M., May, P. C., & Finch, C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res. Mol. Brain Res. 11, 97-106.
140. Potter, H., Nelson, R. B., Das, S., Siman, R., Kayyali, U. S. & Dressler, D. (1992) The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann. N.Y. Acad. Sci. 674, 161-173.
141. Qiu, Z., Strickland, D. K., Hyman, B. T., & Rebeck, G. W. (1999) Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J. Neurochem. 73, 1393-1398.
142. Raynes, J. G., & Bevan, S. (1993) Inhibition of the acute-phase response in a human hepatoma cell line. Agents Actions 38, C66-68.
143. Rebeck, G. W., Harr, S. D., Strickland, D. K. & Hyman, B. T. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
144. Ren, R. F., Hawver, D. B., Kim, R. S., & Flanders, K. C. (1997) Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: Involvement of the TGF-beta type II receptor. Brain Res. Mol. Brain Res. 48, 315-22.
145. Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C. & Brandt, J. (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55.
146. Robinson, M. J., Tessier, P., Poulsom, R. & Hogg, N. (2002) The S100 Family heterodimer, MRP-8/14 binds with high affinity to heparin and the haparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277, 3658-3665.
147. Rogers, J. & Lue, L. F. (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid 3-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333-340.
148. Rozemuller, J. M., Stam, F. C., & Eikelenboom, P. (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119, 75-78.
149. Rozemuller, J. M., Abbink, J. J., Kamp, A. M., Stam, F. C., Hack, C. E., & Eikelenboom, P. (1991) Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol. (Berlin) 82, 200-207.
150. Saito, H., Shultz, L. D., Sinha, M., & Papaconstantinou, J. (1999) Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin. Biochem. Biophys. Res. Commun. 263, 270-275.
151. Sanan, D. A., Weisgraber, K. H., Russel, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., Roses, B., Roses, A. D. & Strittmatter, W. J. (1994) Apolipoprotein E associates with 3 amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860-869.
152. Schuster, M. G., Enriquez, P. M., Curran, P., Cooperman, B. S., & Rubin, H. (1992) Regulation of neutrophil superoxide by antichymotrypsin-chymotrypsin complexes. J. Biol. Chem. 267, 5056-5059.
153. Shaw, K. T., Utsuki, T., Rogers, J., Yu, Q. S., Sambamurti, K., Brossi, A., Ge, Y. W., Lahiri, D. K., & Greig, N. H. (2001) Phenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development. Proc. Natl. Acad. Sci. USA 98, 7605-7610.
154. Sigurdsson, E. M., Lee, J. M., Dong, X. W., Hejna, M. J., & Lorens, S. A. (1997) Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: Behavioral, neurochemical, and time dependent histopathological effects. Neurobiol. Aging 18, 591-608.
155. Siman, R., Card, J. P., Nelson, R. B., & Davis, L. G. (1989) Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3, 275-285.
156. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95, 6460-6464.
157. Sipe, J. D. (1992) Amyloidosis and the acute phase response. Folia Histochem. Cytobiol. 30, 171-173.
158. Snow, A. D., Willmer, J. & Kisilevsky, R. (1987) Sulfated glycosaminoglycans: A common constituent of all amyloids? Lab. Invest. 56, 120-123.
159. Snow, A. D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassel, J., & Wight, T. N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
160. Snow, A. D., Mar, H., Nochlin, D., Sekiguchi, R. T., Kimata, K., Koike, Y. & Wight, T. N. (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137, 1253-1270.
161. Snow, A. D., Mar, H., Nochlin, D., Kresse, H., & Wight, T. N. (1992) Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40, 105-113.
162. Snow, A. D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W. A., & Morgan, D. G. (1994) An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12, 219-234.
163. Stannard, A. K., Riddell, D. R., Sacre, S. M., Tagalakis, A. D., Langer, C., von Eckardstein, A., Cullen, P., Athanasopoulos, T., Dickson, G., & Owen, J. S. (2001) Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Biol. Chem. 276, 46011-46016.
164. Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632.
165. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S. & Roses, A. D. (1993) Apolipoprotein-E: high avidity binding to β-amylid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
166. Styren, S. D., Kamboh, M. I., & DeKosky, S. T. (1998) Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. J. Comp. Neurol. 396, 511-520.
167. Su, J. H., Cummings, B. J., & Cotman, C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801-813.
168. Sun, Y., Wu, S., Bu, G., Onifade, M. K., Patel, S. N., LaDu, M. J., Fagan, A. M., & Holtzman, D. M. (1998) Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18, 3261-3272.
169. 1-42 complex perturbs lipid metabolism and activates transcription factors PPARγ and NFκB in human neuroblastoma (Kelly) cells. J. Neurosci. Res. 67, 511-522.
170. Szczepanik, A. M., Funes, S., Petko, W., & Ringheim, G. E. (2001) IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 113, 49-62.
171. Takemura, R., & Werb, Z. (1984) Modulation of apoprotein E secretion in response to receptor-mediated endocytosis in resident and inflammatory macrophages. J. Exp. Med. 159, 167-178.
172. Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) Amyloidbeta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884.
173. Terui, T., Sano, K., Shirota, H., Kunikata, N., Ozawa, M., Okada, M., Honda, M., Tamura, G., & Tagami, H. (2001) TGF-beta-producing CD43 mediastinal lymph node cells obtained from mice tracheally tolerized to ovalbumin (OVA) suppress both Th1-and Th2-induced cutaneous inflammatory responses to OVA by different mechanisms. J. Immunol. 167, 3661-3667.
174. Uchihara, T., Akiyama, H., Kondo, H., & Ikeda, K. (1997) Activated microglial cells are colocalized with perivascular deposits of amyloid-β protein in Alzheimer's disease brain. Stroke 28, 1948-1950.
175. Wahl, S. M., Hunt, D. A., Bansal, G., McCartney-Francis, N., Ellingsworth, L., & Allen, J. B. (1988) Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta. J. Exp. Med. 168, 1403-1417.
176. Walker, D. G., Lue, L. F., & Beach, T. G. (2001) Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22, 957-966.
177. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) Amyloid beta-protein figrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945-25952.
178. Wisniewski, T., & Frangione, B. (1992) Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
179. Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J. & Frangione, B. (1993) Apolipoprotein E: Binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Comm. 192, 359-365.
180. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T. & Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
181. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G., & Siegel, G. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439-1443.
182. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Lee, H. S., Toggas, S. M., Rockenstein, E. M., & Mucke, L. (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 147, 53-67.
183. Wyss-Coray, T., Lin, C., Sanan, D. A., Mucke, L., & Masliah, E. (2000) Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156, 139-150.
184. Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) TGF-beta1 promotes microglial amyloid-beta clearanc and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-628.
185. Yamin, R., Malgeri, E. G., Sloane, J. A., McGraw, W. T. & Abraham, C. R. (1999) Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-beta peptide degradation. J. Biol. Chem. 274, 18777-18784.
186. Yang, D. S., Small, D. H., Seydel, U., Smith, J. D., Hallmayer, J., Gandy, S. E., & Martins, R. N. (1999) Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience 90, 1217-1226.
187. Yates, S. L., Burgess, L. H., Kocsis-Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine prduction by THP-1 cells and murine microglia. J. Neurochem. 74, 1017-1025.